Analysis of 7965 screening colonoscopies and treatment results of detected colorectal cancers – experiences of one center

• Authors: Andrzej Nowicki , Zbigniew Kula , Marzena Lemanowicz
• Languages of publication: EN

Abstracts

EN

Introduction: Colorectal cancer is one of the most common cancers in both sexes and is one of the leading causes of death in Poland and the world. An effective method to prevent the development of colorectal cancer (CRC) is the detection of polyps during a screening colonoscopy and their removal. Objective: The aim of the study was to evaluate results of screening for early detection of colorectal cancer by colonoscopy. Material and methods: The study was based on analysis of medical records of 7965 patients who underwent colonoscopy as part of the National Screening Program (NSP) for Early Detection of Colorectal Cancer in the 2000–2014 period. Results: Polyps were removed in 2900 (36.4%) patients, among whom 1885 (23.6%) had adenomas, which were more frequent in men (32.9%). Tubular adenomas were observed in 1685 patients (21.1%), tubulo-villous adenomas were detected in 157 patients (2%) and villous adenomas – in 43 (0.5%) of them. Sixty-three (0.79%) colorectal cancers were detected in various clinical stages, including adenocarcinoma in situ in 3 patients. Probability of 5-year survival rate of colorectal cancer amounted to 74% while 10-years survival was reached in 63% of patients. Conclusions: The detection rate of polyps, adenomas and carcinomas thanks to screening colonoscopy was 36.4%, 23.6% and 0.79% respectively, while the probability of 5-year survival was 74%. An improvement in the quality of colonoscopy was observed in subsequent years of the NSP, which translated into better detection of adenomas.

Keywords

EN

National Screening Program for Early Detection of Colorectal Cancer; colorectal cancer; screening colonoscopy

Discipline

• MEDICINE: MEDICINE

• Publisher: Medical Education
• Journal: OncoReview
• Year: 2016
• Volume: 6
• Issue: 3
• Pages: A134-142

Contributors

author

Andrzej Nowicki

• Department of Oncology Nursing, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Poland

author

Zbigniew Kula

• Endoscopy Unit, Oncology Center in Bydgoszcz, Poland

author

Marzena Lemanowicz

• Department of Oncology Nursing, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Poland

References

• 1. Didkowska J, Wojciechowska U, Zatoński W. Nowotwory złośliwe w Polsce w 2011 roku. Centrum Onkologii Instytut im. M. Skłodowskie-Curie. Warszawa 2013.
• 2. Potemski P. Epidemiologia, badania przesiewowe i klasyfikacja zaawansowania klinicznego raka jelita grubego. Onkol Prakt Klin 2010; 6: 283- 289.
• 3. Amri R, Bordeianou LG, Sylla P, Berger DL. Impact of screening colonoscopy on outcomes in colon cancer surgery. JAMA Surg 2013; 148: 747- 754.
• 4. Hawang MJ, Ewans T, Lawrence G et al. Impact of bowel cancer screening on the management of colorectal cancer. Colorectal Disease 2014; 16: 450-458.
• 5. Kotowski B, Kamiński MF, Rupiński M et al. Analiza jakości kolonoskopii w Ogólnopolskim Programie Badań Przesiewowych dla Wczesnego Wykrywania Raka Jelita Grubego. Gastroenterol Klin 2009; 1: 45-53.
• 6. Regula J, Rupiński M, Kraszewska E et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med 2006; 355: 1863-1872.
• 7. Kamiński M, Reguła J, Kraszewska E et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 2010; 362: 1792-1803.
• 8. Schoenfeld PS, Cohen J. Quality indicators for colorectal cancer screening for colonoscopy. Tech Gastrointest Endosc 2013; 15: 59-68.
• 9. Wilkins T, LeClair B, Smolkin M et al. Screening colonoscopies by primary care physicians: a meta-analysis. Fam Med 2009; 7: 65-62.
• 10. Pox CP, Altenhofen L, Brenner H et al. Efficacy of a nationwide screening colonoscopy program for colorectal cancer. Gastroenterology 2012; 142: 1460-1467.
• 11. Friedrich K, Grüter L, Gotthardt D et al. Survival in patients with colorectal cancer diagnosed by screening colonoscopy. Gastrointest Endosc 2015; 82: 133-137.
• 12. Kahi CJ, Imperiale TF, Juliar BE, Rex DK. Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol 2009; 7: 770-775.
• 13. Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ 2014; 9: 348-360.
• 14. Krzakowski M, Bujko K, Drosik K et al. Systemowe leczenie raka okrężnicy i raka odbytnicy- uzgodnienia oparte na wynikach klinicznych badań. Onkol Prakt Klin 2007; 3: 267-285.
• 15. Wełnicki M. Sytuacja epidemiologiczna i możliwości leczenia raka jelita grubego w Polsce. Sł Zdr 2015; 9: 67-73.
• 16. Jassem J, Duchnowska R, Kawecki A et al. Badania kontrolne po leczeniu w najczęstszych nowotworach litych u dorosłych. Nowotwory Journal of Oncology 2014; 5: 415-435.
• 17. Brenner H, Altenhofen L, Stock C, Hoffmeister M. Prevention, early detection, and overdiagnosis of colorectal cancer within 10 years of screening colonoscopy in Germany. Clin Gastroenterol Hepatol 2015; 13: 717-23.
• 18. Dhams S, Nowicki A. Epidemiology and results of treatment of colorectal cancer in Poland. Pol Przegl Chir 2015; 87: 1082-1094.

• Document Type: article